HD-OPM Archive
Topics › Plaque, CAC & CT angiography

FLOWPROMOTE video: atorvastatin shrank total plaque 14%, rosuvastatin plus ezetimibe 21%

Louis Nervegna · Nov 12, 2026 · ♥ 6 reactions · 10 comments · original Facebook post
Plaque, CAC & CT angiographyStatinsPCSK9, ezetimibe & newer drugs
AI summary & key facts

Louis shares a cardiologist's video explaining the FLOWPROMOTE randomized trial and gives the headline numbers. Atorvastatin 40 mg shrank total coronary plaque by about 14% and rosuvastatin 40 mg plus ezetimibe 10 mg by about 21% in 18 months, proven by before-and-after CT angiography.

He does a good job of explaining the plaque reversal that was achieved in the recent FLOWPROMOTE randomized trial.

40mg atorvastatin shrank total plaque by 14% in 18 months.

40mg rosuvastatin + 10mg ezetimibe shrank it by 21% in the same time.

This was proven with full before-and-after CT angiography of the coronary arteries.

#statinreverseHD #statinsHD #ezetimibeHD #flowpromoteHD #ezetimibereverseHD #reverseHD

▶Video · YouTube · Dr AloCardiologist: New Study Shows Soft Plaque Melts Away (FLOWPROMOTE)🚨 A new trial just showed that dangerous soft plaque shrank in 51 out of 52 patients, almost everyone, when treated with rosuvastatin plus ezetimibe. 🔬 Researchers scanned every single coronary artery with CT imaging and plotted the results on a waterfall chart showing plaque regression patient by patient. 🩺 I break down the actual LDL numbers behind this…m.youtube.com

Research cited

← newer: About 10% of people with a zero calcium score still have sigolder: Six statin trials showed 5-17% reversal of total plaque, pro →